Sun L - Search Results

1

Deciphering a profiling based on multiple post-translational modifications functionally associated regulatory patterns and therapeutic opportunities in human hepatocellular carcinoma.

Lao Y, Jin Y, Wu S, Fang T, Wang Q, Sun L, Sun B. Lao Y, et al. Among authors: sun l, sun b. Mol Cancer. 2024 Dec 28;23(1):283. doi: 10.1186/s12943-024-02199-1. Mol Cancer. 2024. PMID: 39732660 Free PMC article.

2

Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas.

Wang J, Xie W, Sun L, Li J, Wu S, Li R, Zhao Y. Wang J, et al. Among authors: sun l. Anal Chim Acta. 2023 Sep 22;1275:341569. doi: 10.1016/j.aca.2023.341569. Epub 2023 Jul 4. Anal Chim Acta. 2023. PMID: 37524462

3

Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies.

Wu S, Xu Y, Zhang J, Ran X, Jia X, Wang J, Sun L, Yang H, Li Y, Fu B, Huang C, Liao P, Sun W. Wu S, et al. Among authors: sun l, sun w. Front Immunol. 2022 Jul 26;13:893943. doi: 10.3389/fimmu.2022.893943. eCollection 2022. Front Immunol. 2022. PMID: 35958562 Free PMC article.

4

SILAC-based quantitative proteomic analysis of secretome between activated and reverted hepatic stellate cells.

Zhang H, Wu P, Chen F, Hao Y, Lao Y, Ren L, Sun L, Sun W, Wei H, Chan DW, Jiang Y, He F. Zhang H, et al. Among authors: sun l, sun w. Proteomics. 2014 Sep;14(17-18):1977-86. doi: 10.1002/pmic.201300539. Epub 2014 Aug 4. Proteomics. 2014. PMID: 24995952

5

Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery.

Sun W, Ma J, Wu S, Yang D, Yan Y, Liu K, Wang J, Sun L, Chen N, Wei H, Zhu Y, Xing B, Zhao X, Qian X, Jiang Y, He F. Sun W, et al. Among authors: sun l. J Proteome Res. 2010 Feb 5;9(2):1020-31. doi: 10.1021/pr9009172. J Proteome Res. 2010. PMID: 20038183

6

In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.

Zhang J, Hao N, Liu W, Lu M, Sun L, Chen N, Wu M, Zhao X, Xing B, Sun W, He F. Zhang J, et al. Among authors: sun l, sun w. Br J Cancer. 2017 Nov 21;117(11):1676-1684. doi: 10.1038/bjc.2017.344. Epub 2017 Oct 12. Br J Cancer. 2017. PMID: 29024941 Free PMC article.

7

Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics.

Zhao Y, Li Y, Liu W, Xing S, Wang D, Chen J, Sun L, Mu J, Liu W, Xing B, Sun W, He F. Zhao Y, et al. Among authors: sun l, sun w. J Proteomics. 2020 Aug 15;225:103780. doi: 10.1016/j.jprot.2020.103780. Epub 2020 Apr 13. J Proteomics. 2020. PMID: 32298775

8

Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.

Sun W, Xing B, Guo L, Liu Z, Mu J, Sun L, Wei H, Zhao X, Qian X, Jiang Y, He F. Sun W, et al. Among authors: sun l. Sci Rep. 2016 May 24;6:26499. doi: 10.1038/srep26499. Sci Rep. 2016. PMID: 27216119 Free PMC article.

9

[Preparation and characterization of monoclonal antibodies against S100A9].

Liu Y, Li X, Zuo W, Chi J, Liu G, Sun L, Jiang J, Liu Y. Liu Y, et al. Among authors: sun l. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Sep;30(9):956-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014. PMID: 25200158 Chinese.

10

Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study.

Chong S, Sun L, Mu G, Hua M, Xiang Q, Cui Y. Chong S, et al. Among authors: sun l. Paediatr Drugs. 2025 Jan 18. doi: 10.1007/s40272-024-00665-3. Online ahead of print. Paediatr Drugs. 2025. PMID: 39826085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,167 results

Search Page

Filters